SUNSHINE LAKE PHARMA CO LTD (6887)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 40.32 |
|---|---|
| 52-week range | 15.01 – 51.70 |
| Return, 1 month / 3 months | +9.1% / +23.4% |
| Return, 1 year / 3 years | −16.0% / – |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 54.1% |
| Worst drawdown (1 year) | -44.9% |
| Average daily value traded | 15.26M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sunshine Lake Pharma is a pharmaceutical company based in Dongguan, China, that develops and makes medicines, chiefly small-molecule drugs, along with the active ingredients used in them. It supplies finished tablets, capsules and other dosage forms, and it also works for other drugmakers as a contract development and manufacturing partner, helping them produce compounds and bring products to market. Its customers include pharmaceutical companies and healthcare businesses in China and abroad.
SUNSHINE LAKE PHARMA CO LTD trades under the code 6887 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SUNSHINE LAKE PHARMA CO LTD (6887) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 40.32 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 620 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 16.0% and over the last three months it rose 23.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -20.7% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 23.4% | ||
| 6-month return | -8.4% | ||
| 12-month return, skipping the last month | -23.0% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 54.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.9% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 15.26M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.8% |
|---|---|
| 1 month | +9.1% |
| 3 months | +23.4% |
| 6 months | −8.4% |
| 1 year | −16.0% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 38.65 / 39.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.66 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.